Life sciences companies supercharged with £277 million in government and private investment

Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants. Four life sciences companies from across the UK will benefit from the first tranche of Life Sciences Innovative Manufacturing Fund (LSIMF) grants £277 million will help fund and advance life sciences...

West Midlands Innovation Accelerator to Spark Growth and Innovation

The West Midlands Combined Authority (WMCA) prepares to launch the West Midlands Innovation Accelerator to bolster the region’s innovation and R&D capability and capacity to spark commercial growth and investment. First announced in the Government’s 2022 Levelling up White Paper, the West Midlands Innovation Accelerator will commence in May 2023, funded...

Medilink Midlands Business Awards 2023 Winners

Previous Next The Medilink Midlands Business Awards 2023, sponsored by the University of Birmingham and the Precision Health Technologies Accelerator Ltd, were held last night and saw thirteen life science companies based in the East and West Midlands receive awards from Start-Up to Outstanding Achievement. A further six companies received...

UK Budget 2023 – Life Sciences Update

The Chancellor of the Exchequer presented his Spring Budget to Parliament on Wednesday 15 March 2023. This Spring Budget highlights the following points for the whole of the life science industry. A lot of emphasis has been given to the UK becoming Global Leader in Science initiatives. The Government could work on...

Polyflon Medical launches new website

Polyflon Medical, UK medical tubing component specialists, have unveiled their brand new website redesign. The company, with over 30 years of experience in the engineering of polymer materials, relaunched their website in order to create a more seamless visitor experience and showcase their range of medical tube components in a...

Albumedix and Heartseed announce Recombumin® as a critical excipient in the manufacture of Heartseed’s HS-001 investigational cell therapy as its first in-human trial commences

Albumedix Ltd ('Albumedix'), Nottingham, United Kingdom, now part of the global life science group Sartorius, and Heartseed Inc ('Heartseed'), Tokyo, Japan, Tuesday 14th March 2023, announce that Recombumin® is a critical component of Heartseed's HS-001, an investigational cardiac remuscularization cell therapy which has commenced first in human dosing. Recombumin, an animal and human...

Medilink Midlands: New Appointments Announced

The Board of Medilink Midlands is delighted to announce two major new appointments. Melanie Davidson has been appointed Interim Chief Executive Officer, and Andrea Dawson as Chief Operating Officer/Chief Finance Officer with immediate effect. Simon Himsworth the previous Chief Executive Officer has now moved onto newer pastures, and we wish...